An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica Frontiers From Angiotensin IV to Small Peptidemimetics Inhibiting Insulin Regulated Aminopeptidase The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Miami Semaglutide Tirzepatide Clinic Weight Loss Shots